These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6135 related articles for article (PubMed ID: 3292617)

  • 41. Synthesis of tyrosinase inhibitory kojic acid derivative.
    Lee YS; Park JH; Kim MH; Seo SH; Kim HJ
    Arch Pharm (Weinheim); 2006 Mar; 339(3):111-4. PubMed ID: 16511808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the influence of hydroquinone in percutaneous application on guinea-pigs.
    Sivchev S; Bazhdekov B; Durmishev A
    Nauchni Tr Vissh Med Inst Sofiia; 1966; 45(4):35-42. PubMed ID: 4226862
    [No Abstract]   [Full Text] [Related]  

  • 43. Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
    Becker JC; Schrama D
    J Invest Dermatol; 2011 Jun; 131(6):1185-7. PubMed ID: 21566576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclization-activated prodrugs. Synthesis, reactivity and toxicity of dipeptide esters of paracetamol.
    Santos C; Mateus ML; dos Santos AP; Moreira R; de Oliveira E; Gomes P
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1595-8. PubMed ID: 15745804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Achromic patch test from hydroquinone monobenzyl ether.
    Sanz de Galdeano C; Aguirre A; Zabala R; Ratón JA; Díaz-Pérez JL
    Contact Dermatitis; 1993 Jul; 29(1):43-4. PubMed ID: 8365157
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibitory effect of rose hip (Rosa canina L.) on melanogenesis in mouse melanoma cells and on pigmentation in brown guinea pigs.
    Fujii T; Ikeda K; Saito M
    Biosci Biotechnol Biochem; 2011; 75(3):489-95. PubMed ID: 21389613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skin delivery potency and antitumor activities of temozolomide ester prodrugs.
    Suppasansatorn P; Wang G; Conway BR; Wang W; Wang Y
    Cancer Lett; 2006 Nov; 244(1):42-52. PubMed ID: 16412562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Depigmentation effect of hydroquinone monomethyl ether].
    Durmischev AL; Davidoff MS
    Dermatol Monatsschr; 1976 Apr; 162(4):306-11. PubMed ID: 955213
    [No Abstract]   [Full Text] [Related]  

  • 49. Cellular interaction and in vitro antitumor activity of lipophilic mitomycin C prodrugs.
    Matsumoto S; Hayashi Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3784-91. PubMed ID: 3124966
    [No Abstract]   [Full Text] [Related]  

  • 50. Esters of L-dopa: structure-hydrolysis relationships and ability to induce circling behaviour in an experimental model of hemiparkinsonism.
    Brunner-Guenat M; Carrupt PA; Lisa G; Testa B; Rose S; Thomas K; Jenner P; Ventura P
    J Pharm Pharmacol; 1995 Oct; 47(10):861-9. PubMed ID: 8583357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
    van den Boorn JG; Picavet DI; van Swieten PF; van Veen HA; Konijnenberg D; van Veelen PA; van Capel T; Jong EC; Reits EA; Drijfhout JW; Bos JD; Melief CJ; Luiten RM
    J Invest Dermatol; 2011 Jun; 131(6):1240-51. PubMed ID: 21326294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez C; Praveen Rao PN; Knaus EE
    J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and pharmacological evaluation of oligoethylene ester derivatives as indomethacin oral prodrugs.
    De Caprariis P; Palagiano F; Bonina F; Montenegro L; D'Amico M; Rossi F
    J Pharm Sci; 1994 Nov; 83(11):1578-81. PubMed ID: 7891278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and anti lipid-peroxidation activity of hydroquinone monoalkyl ethers.
    Nihro Y; Furukawa H; Sogawa S; Wang TC; Miyataka H; Matsumoto H; Miki T; Satoh T
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):576-9. PubMed ID: 8004702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of hydroquinone in the treatment of cutaneous hyperpigmentation in hairless descendants of Mexican hairless dogs (Xoloitzcuintli).
    Kimura T; Doi K
    Lab Anim Sci; 1998 Oct; 48(5):469-75. PubMed ID: 10090060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin.
    Hsieh PW; Al-Suwayeh SA; Fang CL; Lin CF; Chen CC; Fang JY
    Eur J Pharm Biopharm; 2012 Jun; 81(2):369-78. PubMed ID: 22469554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
    Tse TW
    J Dermatolog Treat; 2010 Sep; 21(5):272-5. PubMed ID: 20095963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin lightening creams containing hydroquinone.
    Williams H
    BMJ; 1992 Oct; 305(6859):903-4. PubMed ID: 1458069
    [No Abstract]   [Full Text] [Related]  

  • 59. Pitfalls in clinical trials reveal need for well tolerated, more effective depigmenting agents.
    Saxena S; Andersen RM; Maibach HI
    J Dermatolog Treat; 2015 Oct; 26(5):440-50. PubMed ID: 25669434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of deoxyarbutin on melanogenesis: in vivo comparison with other melanogenesis inhibitor.
    Hamed SH; Sriwiiyanont P; Wickett RR; Boissy R
    J Cosmet Sci; 2004; 55(1):118-9. PubMed ID: 15065582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 307.